Brian P. Sorrentino
Affiliations: | Molecular Therapeutics and Cell Signaling | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Molecular Biology, Immunology, Epidemiology, OncologyGoogle:
"Brian Sorrentino"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bonner MA, Morales-Hernández A, Zhou S, et al. (2021) 3' UTR-truncated HMGA2 overexpression induces non-malignant expansion of hematopoietic stem cells in non-human primates. Molecular Therapy. Methods & Clinical Development. 21: 693-701 |
| Ozog S, Timberlake ND, Hermann K, et al. (2019) Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes. Blood |
| Mamcarz E, Zhou S, Lockey T, et al. (2019) Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. The New England Journal of Medicine. 380: 1525-1534 |
| Fatima S, Zhou S, Sorrentino BP. (2018) Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage tracing mouse model. Experimental Hematology |
| Fukuda Y, Wang Y, Lian S, et al. (2017) Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. Jci Insight. 2 |
| Mamcarz E, Zhou S, Lockey T, et al. (2017) Interim Results from a Phase I/II Clinical Gene Therapy Study for Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency Using a Safety-Modified Lentiviral Vector and Targeted Reduced Exposure to Busulfan Blood. 130: 523-523 |
| De Ravin SS, Wu X, Moir S, et al. (2016) Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Science Translational Medicine. 8: 335ra57 |
| Zhou S, Fatima S, Ma Z, et al. (2016) Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Zhou S, Ma Z, Lu T, et al. (2016) 571. Safe Harbor Targeting of IL2RG Expression Cassettes for Gene Therapy of X-Linked Severe Combined Immunodeficiency (SCID-X1) Molecular Therapy. 24: S228 |
| Bonner MA, Zhou S, Wang Y, et al. (2016) 281. Enforced Expression of a Mutant HMGA2 Gene Leads to Competitive Expansion and High Level Marking of Long-Term Hematopoietic Stem Cells in Transplanted Nemestrina Macaques Molecular Therapy. 24: S112-S113 |